SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-005408
Filing Date
2017-11-08
Accepted
2017-11-08 16:01:16
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 353799
2 CERTIFICATION ipix_ex311.htm EX-31.1 7439
3 CERTIFICATION ipix_ex312.htm EX-31.2 7510
4 CERTIFICATION ipix_ex321.htm EX-32.1 2901
5 CERTIFICATION ipix_ex322.htm EX-32.2 3050
  Complete submission text file 0001477932-17-005408.txt   2999732

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipix-20170930.xml EX-101.INS 519288
7 XBRL TAXONOMY EXTENSION SCHEMA ipix-20170930.xsd EX-101.SCH 61796
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20170930_cal.xml EX-101.CAL 45490
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20170930_def.xml EX-101.DEF 178488
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20170930_lab.xml EX-101.LAB 251619
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20170930_pre.xml EX-101.PRE 232661
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 171186510
SIC: 2834 Pharmaceutical Preparations